Scientists have assessed the novel coronavirus infection in monkeys and found that the immune system’s T cells may contribute to protection against the virus if antibody responses are suboptimal, an advance which may aid in the development of vaccines and therapeutics for COVID-19.
The study, published in the journal Nature, shed light on the role of antibodies and immune cells in protection against SARS-CoV-2 — the virus that causes COVID-19. “In this study, we define the role of antibodies versus T cells in protection against COVID-19 in monkeys. We report that a relatively low antibody titre — the concentration of antibodies in the blood — is needed for protection,” said study co-author Dan Barouch from Beth Israel Deaconess Medical Center (BIDMC) in the US. “Such knowledge will be important in the development of next generation vaccines, antibody-based therapeutics, and public health strategies for COVID-19,” Barouch said.
Earlier studies had…
